My office has also been in contact with FDA on this issue of bioequivalence for a life-saving antibiotic because leading infectious disease experts in my state have expressed concern that FDA did not take appropriate steps to establish this new standard for demonstrating bioequivalence.
Addressing concerns about FDA standards for bioequivalence of a life-saving antibiotic.
Share
More from Arlen Specter
Because it is so important for the public to know how its Government functions, and because the Supreme Court affects the lives of Americans in such great detail.
We have a requirement, as you may know, for 60 Senators to be in agreement before a bill is taken up, and some people--we were two votes short.
Other voices in this conversation
